Elevance Health's stock has seen a significant decline due to recent changes in Medicaid and Medicare programs. These adjustments, announced by government officials, have raised concerns among investors about the potential impact on the company's revenue and profitability.

Market analysts are closely monitoring the situation as these changes could lead to a shift in the healthcare industry, affecting not only Elevance Health but also other major players. The stock's decline reflects broader concerns about the implications of these policy changes on the overall healthcare market.

Investors are advised to stay informed as further developments unfold, which may influence market dynamics and company performance in the future.